AtomVie Global Radiopharma Inc. is a global leader in contract development and manufacturing organisation (CDMO) services, specialising in the Good Manufacturing Practice (GMP) manufacturing and distribution of clinical and commercial radiopharmaceuticals. As a recent spinout from the Centre for Probe Development and Commercialization (CPDC), AtomVie provides a comprehensive suite of scientific, technical, regulatory, quality, logistics, and business expertise combined with a state-of-the-art purpose-built facility for the development of radiotherapeutics from Phase 1 through to the commercial marketplace.

Services include:
– GMP manufacturing of radiopharmaceuticals
– Clinical supply services
– Regulatory compliance assistance
– Quality assurance and quality control
– Logistics and supply chain management
– Business development and market access support

AtomVie Global Radiopharma Inc. is committed to empowering the development of innovative radiopharmaceuticals for its partners in the pharmaceutical industry.